Skip to main content
Livermore
Livermore
ZHEN

Vanguard Group Inc

SEC CIK
0000102909
Latest filing
Jan 29, 2026

EVOK holding history

Evoke Pharma Inc in every 13F filed by Vanguard Group Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

EVOK overviewAll 13F holders of EVOKFull Q4 2025 holdings

Shares (Q4 2025)
0
Sold out in Q4 2025
Value
$0
% of portfolio
0.0%
Quarters held
15
Since Q1 2021
Holdings of EVOK by Vanguard Group Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20250$00.0%−18,759−100.0%Sold outHolders
Q3 202518,759$93.2K<0.1%+18,759NewHolders
Q3 20240$00.0%−2,488−100.0%Sold outConverted for a 1-for-12 splitHolders
Q2 202429,851$15.8K<0.1%00.0%UnchangedHolders
Q1 202429,851$18.2K<0.1%00.0%UnchangedHolders
Q4 202329,851$31.4K<0.1%00.0%UnchangedHolders
Q3 202329,851$41.2K<0.1%00.0%UnchangedHolders
Q2 202329,851$49.3K<0.1%00.0%UnchangedHolders
Q1 202329,851$56.7K<0.1%00.0%UnchangedHolders
Q4 202229,851$80.0K<0.1%00.0%UnchangedHolders
Q3 202229,851$56.0K<0.1%−1,485−4.7%ReducedHolders
Q2 202231,336$102.0K<0.1%−1,085,337−97.2%ReducedHolders
Q1 20221,116,673$553.0K<0.1%−7,971−0.7%ReducedHolders
Q4 20211,124,644$618.0K<0.1%00.0%UnchangedHolders
Q3 20211,124,644$1.46M<0.1%+4,466+0.4%AddedHolders
Q2 20211,120,178$1.53M<0.1%−17,335−1.5%ReducedHolders
Q1 20211,137,513$2.08M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.